New reports show next-level growth for Nucleic Acid Amplification Testing (NAAT) Market - PowerPoint PPT Presentation

About This Presentation

New reports show next-level growth for Nucleic Acid Amplification Testing (NAAT) Market


The Nucleic Acid Amplification Testing (NAAT) market applies both qualitative and quantitative data analysis to present an overview of the future adjacencies around the Nucleic Acid Amplification Testing (NAAT) industry for the forecast period – PowerPoint PPT presentation

Number of Views:39
Slides: 8
Provided by: devinsmith


Transcript and Presenter's Notes

Title: New reports show next-level growth for Nucleic Acid Amplification Testing (NAAT) Market

Nucleic Acid Amplification Testing (NAAT) Market
To Reach USD 4.549 Billion By 2026
Market Summary
High demand for advanced diagnostic techniques,
increasing investment in the field of
diagnostics, favorable initiatives by governments
all over the globe, extensive range of
applications, growing demand from blood banks and
transfusion centers, technological development in
healthcare sector are key factors contributing to
high CAGR of Nucleic Acid Amplification Testing
during forecast period. According to the
current analysis of Reports and Data, the global
Nucleic Acid Amplification Testing (NAAT) market
was valued at USD 2.315 Billion in 2018 and is
expected to reach USD 4.549 Billion by year 2026,
at a CAGR of 8.8 .
Our Approach
Market Summary
  • The study covers Nucleic acid which a complex
    organic substance essential to all forms of life.
    It is present in living cells as RNA and DNA,
    composed of nucleotides linked in a long chain.
    Whereas, Nucleic acid amplification testing is a
    method of testing the blood to detect pathogen
    causing bacteria or virus in in blood, tissue,
    urine, etc.
  • The nucleic acid amplification testing is widely
    used in the field of diagnostics. With market
    players exploring the applications of nucleic
    acid amplification testing, and it is expected to
    be adopted in new disease fields for the
    diagnostics and monitoring purpose. For instance,
    Gen-Probe, Inc., a US based Clinical Diagnostics
    company, introduced three assays based on its
    transcription-mediated amplification technology
    the APTIMA CT assay (ACT), which detects C.
    trachomatis, the APTIMA GC assay (AGC), which
    detects Neisseria gonorrhoeae, and the APTIMA
    COMBO 2 assay (AC2), which detects both
  • Request for a sample of this research report _at_

Our Approach
Market Summary
  • Further key findings from the report suggest
  • Nucleic Acid Amplification testing market is
    growing at a CAGR of 8 in Asia Pacific followed
    by North America and Europe, with 8.6 and 8.5
    CAGR, respectively. Growing demand for the
    advanced diagnostic measures the globe is the
    prominent factor to accelerate the nucleic acid
    amplification testing market growth during
    forecast period across all regions
  • As of 2018, Target Amplification system is the
    dominating Nucleic Acid Amplification Testing
    technique which holds 38.8 of the global
    market. North America regional market is the
    chief revenue generating source for this product
    segment, followed by Europe and Asia-Pacific
  • Probe amplification systems is expected to grow
    at a CAGR of 8.4 . The market segment will reach
    USD 1.5 Billion mark by 2026.
  • Infectious disease application type segment was
    valued at USD 1.03 billion and is expected reach
    USD 1.97 billion by 2026, growing at a CAGR of
  • To identify the key trends in the industry, click
    on the link below https//

Our Approach
Market Summary
  • Key participants include Siemens Healthcare GmbH,
    Abbott Laboratories, Inc., F. Hoffmann-La Roche
    Ltd, Grifols SA, Becton, Illumina Inc., Dickinson
    and Company, Beckman Coulter Inc., Bio-Rad
    Laboratories, and bioMrieux SA
  • For the purpose of this report, Reports and Data
    has segmented the market on the basis of source,
    product, application, and region
  • Technique Type (Revenue, USD Million 20162026)
  • Target Amplification
  • Probe Amplification
  • Signal Amplification

Our Approach
  • Application Type (Revenue, USD Million
  • Infectious Diseases
  • Cancer
  • Personalized Medicine
  • Genetic
  • Regional Outlook (Revenue in USD Million
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Rest of the Europe
  • Order Now https//

About Us
Our Approach
About Us
  • Reports and Data is a market research and
    consulting company that provides syndicated
    research reports, customized research reports,
    and consulting services. Our solutions purely
    focus on your purpose to locate, target and
    analyze consumer behavior shifts across
    demographics, across industries and help clients
    make a smarter business decision. We offer market
    intelligence studies ensuring relevant and
    fact-based research across a multiple industries
    including Healthcare, Technology, Chemicals,
    Power, and Energy. We consistently update our
    research offerings to ensure our clients are
    aware about the latest trends existent in the
    market. Reports and Data has a strong base of
    experienced analysts from varied areas of
  • Contact Us
  • John Watson
  • Head of Business Development
  • Reports And Data Web
  • Direct Line 1-212-710-1370
  • E-mail
Write a Comment
User Comments (0)